$0.030
-0.017 (-57.39%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ITRM Prediction & Forecast by Similar Chart Analysis
Alphio's ITRM stock price prediction model matches the current Iterum Therapeutics PLC tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.03 (+1.21%). The 1-week path is $0.03 (+2.80%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Iterum Therapeutics PLC Stock?
Iterum Therapeutics PLC (ITRM) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock faces significant challenges, including a potential delisting from Nasdaq, financial instability, and lack of positive trading signals. Additionally, there are no recent positive news or catalysts to support a bullish outlook.
ITRM stock price ended at $0.03 on Tuesday, after losing -57.39%
Iterum Therapeutics PLC (ITRM) last closed at $0.03, losing -57.39%. These facts feed the 1-day and 1-week ITRM price prediction above.
Analyst Consensus
Iterum Therapeutics PLC (ITRM): 4 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Iterum Therapeutics PLC (ITRM) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches ITRM, ranked by similarity.
Seasonality analysis for ITRM
Historically the probability of a positive August return for ITRM is 0.00%. January offers the highest probability of a positive month at 44.26%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ITRM
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $0.94 | $1.09 | $1.24 | +3517.90% |
| Sep 2026 | $0.86 | $0.97 | $1.15 | +3129.38% |
| Oct 2026 | $0.83 | $1.01 | $1.20 | +3261.37% |
| Nov 2026 | $0.95 | $1.11 | $1.26 | +3589.32% |
| Dec 2026 | $0.78 | $0.82 | $0.98 | +2626.89% |
In 2026, Iterum Therapeutics PLC (ITRM) is projected to range from $0.78 to $1.26.
Iterum Therapeutics PLC 2026 monthly forecast
In Aug 2026, Iterum Therapeutics PLC is projected to average $1.09, with a low of $0.94 and high of $1.24.
In Sep 2026, Iterum Therapeutics PLC is projected to average $0.97, with a low of $0.86 and high of $1.15.
In Oct 2026, Iterum Therapeutics PLC is projected to average $1.01, with a low of $0.83 and high of $1.20.
In Nov 2026, Iterum Therapeutics PLC is projected to average $1.11, with a low of $0.95 and high of $1.26.
In Dec 2026, Iterum Therapeutics PLC is projected to average $0.82, with a low of $0.78 and high of $0.98.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.